These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 21074284

  • 1. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese.
    Saxelin M, Lassig A, Karjalainen H, Tynkkynen S, Surakka A, Vapaatalo H, Järvenpää S, Korpela R, Mutanen M, Hatakka K.
    Int J Food Microbiol; 2010 Dec 15; 144(2):293-300. PubMed ID: 21074284
    [Abstract] [Full Text] [Related]

  • 2. Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids.
    Hatakka K, Mutanen M, Holma R, Saxelin M, Korpela R.
    J Am Coll Nutr; 2008 Aug 15; 27(4):441-7. PubMed ID: 18978162
    [Abstract] [Full Text] [Related]

  • 3. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
    Savard P, Lamarche B, Paradis ME, Thiboutot H, Laurin É, Roy D.
    Int J Food Microbiol; 2011 Sep 01; 149(1):50-7. PubMed ID: 21296446
    [Abstract] [Full Text] [Related]

  • 4. The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon.
    Hatakka K, Holma R, El-Nezami H, Suomalainen T, Kuisma M, Saxelin M, Poussa T, Mykkänen H, Korpela R.
    Int J Food Microbiol; 2008 Dec 10; 128(2):406-10. PubMed ID: 18945506
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form.
    Piano MD, Carmagnola S, Ballarè M, Balzarini M, Montino F, Pagliarulo M, Anderloni A, Orsello M, Tari R, Sforza F, Mogna L, Mogna G.
    J Clin Gastroenterol; 2012 Oct 10; 46 Suppl():S85-92. PubMed ID: 22955366
    [Abstract] [Full Text] [Related]

  • 6. The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial.
    Ivey KL, Hodgson JM, Kerr DA, Thompson PL, Stojceski B, Prince RL.
    Nutr Metab Cardiovasc Dis; 2015 Jan 10; 25(1):46-51. PubMed ID: 25171898
    [Abstract] [Full Text] [Related]

  • 7. Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB-12 (BB-12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB-12 and Lactobacillus rhamnosus GG.
    Poutsiaka DD, Mahoney IJ, McDermott LA, Stern LL, Thorpe CM, Kane AV, Baez-Giangreco C, McKinney J, Davidson LE, Leyva R, Goldin B, Snydman DR.
    J Appl Microbiol; 2017 May 10; 122(5):1321-1332. PubMed ID: 28256070
    [Abstract] [Full Text] [Related]

  • 8. Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp. lactis BB-12 on Fecal Microbiota, Gut Transit Time, and Short-Chain Fatty Acids in Healthy Young Adults.
    Ba Z, Lee Y, Meng H, Kris-Etherton PM, Rogers CJ, Lewis ZT, Mills DA, Furumoto EJ, Rolon ML, Fleming JA, Roberts RF.
    mSphere; 2021 Aug 25; 6(4):e0008421. PubMed ID: 34232082
    [Abstract] [Full Text] [Related]

  • 9. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
    Dommels YE, Kemperman RA, Zebregs YE, Draaisma RB, Jol A, Wolvers DA, Vaughan EE, Albers R.
    Appl Environ Microbiol; 2009 Oct 25; 75(19):6198-204. PubMed ID: 19684171
    [Abstract] [Full Text] [Related]

  • 10. Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers.
    Kabeerdoss J, Devi RS, Mary RR, Prabhavathi D, Vidya R, Mechenro J, Mahendri NV, Pugazhendhi S, Ramakrishna BS.
    Nutr J; 2011 Dec 23; 10():138. PubMed ID: 22196482
    [Abstract] [Full Text] [Related]

  • 11. Absence of adverse events in healthy individuals using probiotics--analysis of six randomised studies by one study group.
    Tapiovaara L, Lehtoranta L, Poussa T, Mäkivuokko H, Korpela R, Pitkäranta A.
    Benef Microbes; 2016 Dec 23; 7(2):161-9. PubMed ID: 26689224
    [Abstract] [Full Text] [Related]

  • 12. Effects of multispecies probiotic combination on helicobacter pylori infection in vitro.
    Myllyluoma E, Ahonen AM, Korpela R, Vapaatalo H, Kankuri E.
    Clin Vaccine Immunol; 2008 Sep 23; 15(9):1472-82. PubMed ID: 18579692
    [Abstract] [Full Text] [Related]

  • 13. Synbiotic Intervention with Lactobacilli, Bifidobacteria, and Inulin in Healthy Volunteers Increases the Abundance of Bifidobacteria but Does Not Alter Microbial Diversity.
    Rubin IMC, Mollerup S, Broholm C, Baker A, Holm MKA, Pedersen MS, Pinholt M, Westh H, Petersen AM.
    Appl Environ Microbiol; 2022 Oct 11; 88(19):e0108722. PubMed ID: 36165644
    [Abstract] [Full Text] [Related]

  • 14. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
    Klein A, Friedrich U, Vogelsang H, Jahreis G.
    Eur J Clin Nutr; 2008 May 11; 62(5):584-93. PubMed ID: 17440520
    [Abstract] [Full Text] [Related]

  • 15. A probiotic mixture including galactooligosaccharides decreases fecal β-glucosidase activity but does not affect serum enterolactone concentration in men during a two-week intervention.
    Kekkonen RA, Holma R, Hatakka K, Suomalainen T, Poussa T, Adlercreutz H, Korpela R.
    J Nutr; 2011 May 11; 141(5):870-6. PubMed ID: 21411613
    [Abstract] [Full Text] [Related]

  • 16. Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus?
    Collado MC, Meriluoto J, Salminen S.
    J Dairy Sci; 2007 Jun 11; 90(6):2710-6. PubMed ID: 17517710
    [Abstract] [Full Text] [Related]

  • 17. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
    Saarela M, Maukonen J, von Wright A, Vilpponen-Salmela T, Patterson AJ, Scott KP, Hämynen H, Mättö J.
    Int J Antimicrob Agents; 2007 Mar 11; 29(3):271-80. PubMed ID: 17207972
    [Abstract] [Full Text] [Related]

  • 18. Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants.
    Korpela K, Salonen A, Vepsäläinen O, Suomalainen M, Kolmeder C, Varjosalo M, Miettinen S, Kukkonen K, Savilahti E, Kuitunen M, de Vos WM.
    Microbiome; 2018 Oct 16; 6(1):182. PubMed ID: 30326954
    [Abstract] [Full Text] [Related]

  • 19. Lactobacillus rhamnosus R11 consumed in a food supplement survived human digestive transit without modifying microbiota equilibrium as assessed by real-time polymerase chain reaction.
    Firmesse O, Mogenet A, Bresson JL, Corthier G, Furet JP.
    J Mol Microbiol Biotechnol; 2008 Oct 16; 14(1-3):90-9. PubMed ID: 17957115
    [Abstract] [Full Text] [Related]

  • 20. Effect of yogurt containing Bifidobacterium animalis subsp . lactis DN-173010 probiotic on dental plaque and saliva in orthodontic patients.
    Pinto GS, Cenci MS, Azevedo MS, Epifanio M, Jones MH.
    Caries Res; 2014 Oct 16; 48(1):63-8. PubMed ID: 24217196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.